Fallon John A. Insider Trading Activity

Average Profitability
26.87%
Insider Buys Quantity
1
Insider Buys Sum
$50,302.50
Insider Sells Quantity
10
Insider Sells Sum
$9.61M

Insider Activity of Fallon John A.

According to the SEC Form 4 filings, Fallon John A., being in a position of

  1. director at Collegium Pharmaceutical, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 34853 shares for $1.65M,
    over all time since 2016-08-12, has bought 4750 shares for $50,303, and sold 34853 shares for $1.65M.

Biography of Fallon John A.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,645,5361100

Comparison of Insiders on Amount of Buys and Sells

2025-11-12SaleCollegium Pharmaceutical, Inc.
COLL
director
34,853
0.1231%
$47.21$1.65M-26.16%
2021-05-21SaleInsulet Corporation
PODD
director
5,822
0.0087%
$253.36$1.48M+7.27%
2020-11-04SaleInsulet Corporation
PODD
director
6,000
0.0052%
$129.44$776,610+19.49%
2020-11-02SaleInsulet Corporation
PODD
director
8,000
0.0074%
$130.06$1.04M+27.74%
2019-11-18SaleInsulet Corporation
PODD
director
9,525
0.0156%
$181.41$1.73M+7.8%
2019-11-15SaleInsulet Corporation
PODD
director
5,000
0.0082%
$180.06$900,325+8.99%
2019-03-20SaleInsulet Corporation
PODD
director
5,000
0.0085%
$100.00$500,000+52.22%
2019-03-12SaleInsulet Corporation
PODD
director
5,000
0.0083%
$95.00$475,000+57.54%
2019-03-06SaleInsulet Corporation
PODD
director
10,000
0.0169%
$92.64$926,400+62.11%
2018-03-14SaleInsulet Corporation
PODD
director
18,000
0.0306%
$84.10$1.51M+2.56%
2016-08-12PurchaseCollegium Pharmaceutical, Inc.
COLL
director
4,750
0.0203%
$10.59$50,303+26.87%
Total: 11
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.